AI assistant
Axogen, Inc. — Director's Dealing 2012
Feb 13, 2012
32414_dirs_2012-02-13_402abf23-e166-46c3-a434-3885fbaf409f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-12-31
Reporting Person: De Novo Ventures II, L.P. (10% Owner)
Reporting Person: De Novo Management II, L.L.C. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-10 | Common Stock | A | 5455 | $2.75 | Acquired | 1431847 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-10 | Stock Option | $2.75 | A | 12000 | Acquired | 2018-10-10 | Common Stock (12000) | Indirect |
Footnotes
F1: These shares were granted in lieu of cash payment to De Novo Ventures II, L.P. ("De Novo"), as compensation for Mr. Joseph Mandato's service as a non-employee director of AxoGen, Inc. through December 31, 2012.
F2: The shares are owned by De Novo Ventures II, L.P. ("De Novo"). De Novo Management II, LLC is the sole general partner of De Novo.
F3: The options were granted to De Novo as compensation to Mr. Mandato for service on the board of directors. All options vested on the date of grant.